CLINICAL_TRIALS
research
· 2017-03-03
Clinical Trial Update: Effects of Genistein Aglycone in Glucocorticoid Induced Osteoporosis [Phase 2, Phase 3]
Summary
Phase 2/Phase 3 clinical trial evaluating genistein aglycone for glucocorticoid-induced osteoporosis; current status is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Messina | Conditions: Osteoporosis, Steroid Induced | Phase 2, Phase 3 | Status: UNKNOWN